Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zhi-Jun Wuxiao"'
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 5, Pp 579-581 (2021)
Externí odkaz:
https://doaj.org/article/bb474f3284d443d0a6749d4a6404a186
Autor:
Hua Wang, Bi-bo Fu, Zhi-jun Wuxiao, Ya-jun Li, Li Huang, Jie Ma, Zhi-min Zhai, Jing Guo, Yuan-bin Wu, Zhen-shu Xu, Jia Feng, Sheng-sheng Zhou, Ting-ting Chen, Xing-gui Chen, Guo-wei Li, Ting-zhi Liu, Hai-bin Huang, Run-hui Zheng, Yong-hua Li, Hong-fang Tao, Fu-ming Zi, Fan Wu, Juan Wang, Hui Zeng, Cai-bo Fu, Robert Peter Gale, Zhong-jun Xia, Yang Liang
Publikováno v:
Leukemia. 36:2724-2728
Autor:
Chun Li1, Zhi-Jun Wuxiao2, Xiaoqin Chen1, Guanjun Chen1, Yue Lu1, Zhongjun Xia1 ziazhj@sysu.cc.org.cn, Yang Liang1 liangyang@sysucc.org.cn, Hua Wang1 wanghua@syucc.org.cn
Publikováno v:
Cancer Research & Treatment. Apr2020, Vol. 52 Issue 2, p573-585. 13p.
Autor:
Run-Cong Nie, Jinyuan Li, Pei-dong Chi, Qian-yi Zhang, Tobias Herold, Wolfgang Hiddemann, Yun Wang, Yong-qing Wang, Xiong Zhang, Yan-Yu Cai, Yu Zhang, Ze-lin Liu, Yang Liang, San-bin Wang, Robert Peter Gale, Yong-zhong Su, Xin Du, Klaus H. Metzeler, Tong-hua Yang, Qing Zhang, Zhe-Yuan Qin, Yun Zeng, Xin-mei Zhang, Yuan-bin Wu, Na Zhong, Jian-wei Wu, Bei Zhang, Zhi-jun Wuxiao, Xue-Yi Pan, Qifa Liu, Zhi-wei Liang, Shun-Qing Wang, Jing-bo Xu, Si-Liang Chen, Bingyi Wu, Ruo-zhi Xiao
Publikováno v:
Clinical Cancer Research. 27:255-266
Purpose: Prediction models for acute myeloid leukemia (AML) are useful, but have considerable inaccuracy and imprecision. No current model includes covariates related to immune cells in the AML microenvironment. Here, an immune risk score was explore
Autor:
Qunhao Su, Shi Tao, Xinbao Hao, Hua Wang, Lu Xu, Yu Chen, Zhi-Jun Wuxiao, Min Hu, Haiyan Zhou
Publikováno v:
Journal of Biomaterials and Tissue Engineering. 9:615-622
Rituximab is an IgG1 monoclonal antibody approved for the treatment of diffuse large B-cell lymphoma (DLBCL); however, its efficacy is poor in some patients. Previous studies indicate that the difference in efficacy may be due to antibody-dependent c
Autor:
Zhihua Yao, Yanyan Liu, Li Fei, Jifeng Feng, Weilun Zhou, Fancong Kong, Zhi-Jun Wuxiao, Jianqiu Wu
Publikováno v:
Blood. 136:50-51
Background For patients with relapse/refractory(R/R) Diffuse Large B Cell Lymphoma (DLBCL), intensive therapy (such as R-ICE, R-DHAP) followed by autologous stem cell transplant (ASCT) can provide potential cure. However, not all patients would be el
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 16:747-751
Background: Stage III colon cancer patients demonstrate diverse clinical outcomes. The aim of this study was to develop a prognostic model in order to better predict their survival. Materials and Methods: From 2004 to 2010, 548 patients were retrospe
Autor:
Wen Qi Jiang, Zhi hui Wang, Xiao Qin Chen, Ke Feng Wang, Pan Pan Liu, Zhi jun Wuxiao, Su Li, Bo yang Chang, Zhong Jun Xia
Publikováno v:
Medical oncology (Northwood, London, England). 31(12)
Patients with stage IE/IIE natural killer T (NK/T) cell lymphomas have discrepant survival outcome. This study aims to establish a prognostic model based on the pretreatment platelet lymphocyte ratio (PLR) specifically for localized extranodal NK/T c